JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Electro-orchidogram: a non-invasive diagnostic tool in testicular pathologies.

BACKGROUND: We investigated the hypothesis that the transcutaneous electro-orchidogram (EOG) can act as a diagnostic tool in testicular pathological conditions.

MATERIAL/METHODS: Three electrodes were applied to the scrotal skin of 21 healthy volunteers (controls), 12 patients with acute epididymo-orchitis (EO), 8 with testicular torsion (TT), 10 with unilateral undescended testicle (UT), and 9 with testicular seminoma (TS). Recordings were performed before and 48 hours and 1, 3, and 6 months after treatment. Semen analysis was done 1, 3, and 6 months post-treatment.

RESULTS: Recordings from healthy volunteers showed slow waves (SWs) with similar wave variables from the three electrodes of the same individual. Patients with EO exhibited increased SW variables (p<0.05) during acute stage, which normalized in 8 and diminished in 4 patients 1, 3, and 6 months after inflammatory process resolution. Post resolution, the 8 patients had normospermia and the 4 oligospermia. In TT, SWs were absent during torsion and after detorsion in 7 patients; SWs and semen normalized in 1 patient 6 months after detorsion. The UT showed absent SWs up to 6 months post-descent; semen remained oligospermic. Testicles with TS exhibited areas with SWs and silent areas.

CONCLUSIONS: Testicles in the above pathological conditions showed electro-orchidographic changes associated with changes in semen character. Repeated EOG could demonstrate the progress of the pathological condition in the testicle. The non-invasive EOG may act as a diagnostic and follow-up tool in some testicular pathological conditions after further studies have been performed in this issue.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app